Over the past decade, cancer research has yielded a wealth of therapeutic options for patients for many different subtypes of cancer, as well as greater knowledge of this disease.
The 2022 symposium will feature expert presentations on:
- Clonal Expansion in Normal and Pathological Tissues: It's All a Matter of Fitness
- Unleashing the Immune System to Develop Therapeutic Strategies
- Integrated Immune-Microbiome Biomarker Discovery
- Clinical Data Science
There will also be an exciting panel discussion: The Patient Is the Focus: Breakthroughs From Bench to Bedside, Clinical and Multiomics Integration and High Value Cancer Care.
Please see the symposium agenda for more details.
2022 Keynote Speakers:
Ernst W. Bertner Memorial Award Lecture and
Tyler Jacks, Ph.D.
President, Break Through Cancer
David H. Koch Professor of Biology
Massachusetts Institute of Technology
Learn more about the Bertner Memorial Award and view previous recipients.
Heath Memorial Award Lecture and Presentation
Alan Ashworth, Ph.D., F.R.S.
E. Dixon Distinguished Professor in Oncology
University of California, San Francisco
Learn more about the Heath Memorial Award and view previous recipients.
Wilson S. Stone Memorial Award Lecture and Presentation
Simona Colla, Ph.D.
Associate Professor, Department of Leukemia
MD Anderson Cancer Center
Learn more about the Stone Memorial Award and view previous recipients.
Executive Sponsor: Executive Sponsor: Giulio Draetta, M.D., Ph.D., Chief Scientific Officer
Please email ResearchSymposium@mdanderson.org if you have any questions.